ClinicalTrials.Veeva

Menu

Hydrogen-rich Water and Treatment of Mucositis Caused by Radiation Therapy in Head and Neck Cancer Patients

Stony Brook University logo

Stony Brook University

Status and phase

Completed
Early Phase 1

Conditions

Mucositis Oral

Treatments

Dietary Supplement: Control
Dietary Supplement: Hydrogen tablets

Study type

Interventional

Funder types

Other

Identifiers

NCT05278260
SBU-HYDROGEN-HN-RT

Details and patient eligibility

About

This study explores the effects of hydrogen-rich water on alleviating the radiation-induced acute mucositis in head and neck cancer patients

Enrollment

24 patients

Sex

All

Ages

18+ years old

Volunteers

No Healthy Volunteers

Inclusion criteria

  • Diagnosis of a biopsy proven head and neck cancer, early or advanced stage, primary or recurrent tumor,
  • Planning to receive daily fractionated radiotherapy for over 4 weeks' duration
  • Karnofsky Performance Score (KPS) of at least 70
  • Able to describe pain
  • Able to swallow food and water
  • Able to sign consent

Exclusion criteria

Trial design

Primary purpose

Supportive Care

Allocation

Randomized

Interventional model

Parallel Assignment

Masking

Quadruple Blind

24 participants in 2 patient groups, including a placebo group

Control
Placebo Comparator group
Treatment:
Dietary Supplement: Control
Active
Experimental group
Treatment:
Dietary Supplement: Hydrogen tablets

Trial contacts and locations

1

Loading...

Central trial contact

Clare Moran, NP; Caterina Vacchi-Suzzi, PhD

Data sourced from clinicaltrials.gov

Clinical trials

Find clinical trialsTrials by location
© Copyright 2026 Veeva Systems